NasdaqCM - Delayed Quote USD

Aptorum Group Limited (APM)

0.8609
-0.0341
(-3.81%)
At close: May 9 at 4:00:00 PM EDT
0.8609
0.00
(0.00%)
After hours: May 9 at 4:00:09 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
431.3780
1,295.8890
1,541.7780
Cost of Revenue
0
0
420.8120
1,215.8240
1,459.9240
Gross Profit
0
0
10.5660
80.0650
81.8540
Operating Expense
3,002.2980
3,002.2980
10,611.8020
17,253.6790
19,289.2890
Operating Income
-3,002.2980
-3,002.2980
-10,601.2360
-17,173.6140
-19,207.4350
Net Non Operating Interest Income Expense
-146.9240
-146.9240
-121.1450
146.5880
-93.6010
Other Income Expense
-1,008.5150
-1,008.5150
6,381.4060
5,501.9240
-7,813.2570
Pretax Income
-4,157.7370
-4,157.7370
-4,340.9750
-11,525.1020
-27,114.2930
Net Income Common Stockholders
-4,267.8060
-4,267.8060
-2,824.6470
-9,799.5600
-25,048.3890
Diluted NI Available to Com Stockholders
-4,267.8060
-4,267.8060
-2,824.6470
-9,799.5600
-25,048.3890
Basic EPS
-0.78
--
-0.62
-2.75
-7.15
Diluted EPS
-0.78
--
-0.62
-2.75
-7.15
Basic Average Shares
5,453.1030
--
4,521.1330
3,569.4840
3,503.3960
Diluted Average Shares
5,453.1030
--
4,521.1330
3,569.4840
3,503.3960
Rent Expense Supplemental
97.2530
97.2530
213.7010
265.5580
288.8060
Total Expenses
3,002.2980
3,002.2980
11,032.6140
18,469.5030
20,749.2130
Net Income from Continuing & Discontinued Operation
-4,267.8060
-4,267.8060
-2,824.6470
-9,799.5600
-25,048.3890
Normalized Income
-3,258.7270
-3,258.7270
-9,169.2690
-15,253.4770
-17,083.8670
Interest Income
--
--
--
146.5880
--
Interest Expense
--
--
--
--
93.6010
Net Interest Income
-146.9240
-146.9240
-121.1450
146.5880
-93.6010
EBIT
-3,002.2980
-3,002.2980
-10,601.2360
-17,173.6140
-19,207.4350
EBITDA
-2,696.7320
-2,696.7320
-9,223.6370
-15,617.0730
-18,014.8570
Reconciled Cost of Revenue
0
0
420.8120
1,215.8240
1,459.9240
Reconciled Depreciation
305.5660
305.5660
1,377.5990
1,556.5410
1,192.5780
Net Income from Continuing Operation Net Minority Interest
-4,267.8060
-4,267.8060
-2,824.6470
-9,799.5600
-25,048.3890
Total Unusual Items Excluding Goodwill
-1,009.0790
-1,009.0790
6,344.6220
5,453.9170
-7,964.5220
Total Unusual Items
-1,009.0790
-1,009.0790
6,344.6220
5,453.9170
-7,964.5220
Normalized EBITDA
-1,687.6530
-1,687.6530
-15,568.2590
-21,070.9900
-10,050.3350
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 12/18/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SONN Sonnet BioTherapeutics Holdings, Inc.
1.2800
-2.29%
 
BPTH Bio-Path Holdings, Inc.
0.1630
-0.06%
 
MBRX Moleculin Biotech, Inc.
1.0500
+3.96%
 
TRAW Traws Pharma, Inc.
1.3300
-5.00%
 
CNSP CNS Pharmaceuticals, Inc.
1.1400
+2.70%
 
RLYB Rallybio Corporation
0.2930
0.00%
 
NLSP NLS Pharmaceutics AG
1.6400
-3.53%
 
SNGX Soligenix, Inc.
1.9800
+0.51%
 
ENTO Entero Therapeutics, Inc.
0.4190
+5.09%
 
ORGS Orgenesis Inc.
2.0800
+9.47%